Healthcare
Thursday, April 14, 2016
BRIEF-Merrimack Pharma enters privately-negotiated conversion agreements with certain holders of 4.50 pct convertible senior notes due 2020
* Entered into privately-negotiated conversion agreements
with certain holders of 4.50% convertible senior notes due 2020
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment